(Q45193842)

English

Sustained homocysteine-lowering effect over time of folic acid-based multivitamin therapy in stroke patients despite increasing folate status in the population

scientific article published on 17 December 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

10 December 2017

Sustained homocysteine-lowering effect over time of folic acid-based multivitamin therapy in stroke patients despite increasing folate status in the population (English)

1 reference

Europe PubMed Central

10 December 2017

1 reference

based on heuristic

inferred from title

Graeme J. Hankey

1

1 reference

Europe PubMed Central

10 December 2017

John W. Eikelboom

2

1 reference

Europe PubMed Central

10 December 2017

author name string

Loh K

3

1 reference

Europe PubMed Central

10 December 2017

Tang M

4

1 reference

Europe PubMed Central

10 December 2017

Pizzi J

5

1 reference

Europe PubMed Central

10 December 2017

Thom J

6

1 reference

Europe PubMed Central

10 December 2017

Yi Q

7

1 reference

Europe PubMed Central

10 December 2017

publication date

17 December 2004

1 reference

Europe PubMed Central

10 December 2017

Cerebrovascular Diseases

1 reference

Europe PubMed Central

10 December 2017

19

1 reference

Europe PubMed Central

10 December 2017

2

1 reference

Europe PubMed Central

10 December 2017

110-116

1 reference

Europe PubMed Central

10 December 2017

Homocysteine and vascular disease

1 reference

https://api.crossref.org/works/10.1159%2F000082788

21 January 2018

Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence

1 reference

https://api.crossref.org/works/10.1159%2F000082788

21 January 2018

Vitamin Intervention for Stroke Prevention (VISP) trial: rationale and design.

1 reference

https://api.crossref.org/works/10.1159%2F000082788

21 January 2018

Power Shortage: clinical trials testing the "homocysteine hypothesis" against a background of folic acid-fortified cereal grain flour

1 reference

https://api.crossref.org/works/10.1159%2F000082788

21 January 2018

Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial

1 reference

https://api.crossref.org/works/10.1159%2F000082788

21 January 2018

The VITATOPS (Vitamins to Prevent Stroke) Trial: rationale and design of an international, large, simple, randomised trial of homocysteine-lowering multivitamin therapy in patients with recent transient ischaemic attack or stroke

1 reference

https://api.crossref.org/works/10.1159%2F000082788

21 January 2018

Is there really a power shortage in clinical trials testing the "homocysteine hypothesis?".

1 reference

https://api.crossref.org/works/10.1159%2F000082788

21 January 2018

Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis

1 reference

https://api.crossref.org/works/10.1159%2F000082788

21 January 2018

Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis

1 reference

https://api.crossref.org/works/10.1159%2F000082788

21 January 2018

Identifiers

10.1159/000082788

1 reference

Europe PubMed Central

10 December 2017

release_azsti5ebivcovimxda6zss7xwq

1 reference

https://api.fatcat.wiki/v0/release/azsti5ebivcovimxda6zss7xwq

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

10 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45193842&oldid=2069673835"